Michael Aviram

Haifa, HA 31096, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis.

Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis.

Journal: Redox biology

Published: March 14, 2022

Genetic variants associated with cardiovascular diseases and related risk factors highlight novel potential therapeutic approaches.

Genetic variants associated with cardiovascular diseases and related risk factors highlight novel potential therapeutic approaches.

Journal: Current opinion in lipidology

Published: March 02, 2021

Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.

Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis.

Journal: Cell reports

Published: January 11, 2021

Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease.

Editorial: Nitro-fatty acids: novel drug candidates for the co-treatment of atherosclerosis and nonalcoholic fatty liver disease.

Journal: Current opinion in lipidology

Published: March 06, 2020

Soybean Oil Modulates the Gut Microbiota Associated with Atherogenic Biomarkers.

Soybean Oil Modulates the Gut Microbiota Associated with Atherogenic Biomarkers.

Journal: Microorganisms

Published: February 11, 2020

Prednisone and Its Active Metabolite Prednisolone Attenuate Lipid Accumulation in Macrophages.

Prednisone and Its Active Metabolite Prednisolone Attenuate Lipid Accumulation in Macrophages.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: October 26, 2019

Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome.

Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome.

Journal: Science translational medicine

Published: August 27, 2019

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.

Journal: EBioMedicine

Published: October 12, 2018

Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.

Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism.

Journal: Current opinion in lipidology

Published: August 29, 2018

Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues.

Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues.

Journal: Lipids

Published: July 09, 2018

Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article.

Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article.

Journal: Rambam Maimonides medical journal

Published: June 27, 2018

Pulmonary involvement in Niemann-Pick C type 1.

Pulmonary involvement in Niemann-Pick C type 1.

Journal: European journal of pediatrics

Published: May 29, 2018

Showing 1-12 of 87

Last Updated: 09/26/2026